
### [MONDO:0019237](http://purl.obolibrary.org/obo/MONDO_0019237)
**Label:** inborn disorder of pyridoxine metabolism

**Subclasses:** [MONDO:0015005](http://purl.obolibrary.org/obo/MONDO_0015005) (epilepsy, early-onset, vitamin B6-dependent; EPVB6D), [MONDO:0012407](http://purl.obolibrary.org/obo/MONDO_0012407) (Pyridoxal phosphate-responsive seizures), [MONDO:0009945](http://purl.obolibrary.org/obo/MONDO_0009945) (pyridoxine-dependent epilepsy), 

**Mapped go classes:** [GO:0030170](http://purl.obolibrary.org/obo/GO_0030170) (pyridoxal phosphate binding), [GO:0010181](http://purl.obolibrary.org/obo/GO_0010181) (FMN binding), [GO:0004043](http://purl.obolibrary.org/obo/GO_0004043) (L-aminoadipate-semialdehyde dehydrogenase activity), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0004733](http://purl.obolibrary.org/obo/GO_0004733) (pyridoxamine-phosphate oxidase activity), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0008615](http://purl.obolibrary.org/obo/GO_0008615) (pyridoxine biosynthetic process), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0043010](http://purl.obolibrary.org/obo/GO_0043010) (camera-type eye development), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0033339](http://purl.obolibrary.org/obo/GO_0033339) (pectoral fin development), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0042823](http://purl.obolibrary.org/obo/GO_0042823) (pyridoxal phosphate biosynthetic process), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0016638](http://purl.obolibrary.org/obo/GO_0016638) (oxidoreductase activity, acting on the CH-NH2 group of donors), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0009443](http://purl.obolibrary.org/obo/GO_0009443) (pyridoxal 5'-phosphate salvage), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0004029](http://purl.obolibrary.org/obo/GO_0004029) (aldehyde dehydrogenase (NAD) activity), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005758](http://purl.obolibrary.org/obo/GO_0005758) (mitochondrial intermembrane space), [GO:0008802](http://purl.obolibrary.org/obo/GO_0008802) (betaine-aldehyde dehydrogenase activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0048037](http://purl.obolibrary.org/obo/GO_0048037) (cofactor binding), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), 

**Class expressions from DL-Learner:**

- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 54.17%
- [GO:0005758](http://purl.obolibrary.org/obo/GO_0005758) (mitochondrial intermembrane space) 54.17%
- [GO:0031970](http://purl.obolibrary.org/obo/GO_0031970) (organelle envelope lumen) and [GO:0044444](http://purl.obolibrary.org/obo/GO_0044444) (cytoplasmic part) 54.17%
- [GO:0031970](http://purl.obolibrary.org/obo/GO_0031970) (organelle envelope lumen) and [GO:0044429](http://purl.obolibrary.org/obo/GO_0044429) (mitochondrial part) 54.17%
- Thing 52.22%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 39.52%
- [GO:0031970](http://purl.obolibrary.org/obo/GO_0031970) (organelle envelope lumen) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0090620](http://purl.obolibrary.org/obo/GO_0090620) (obsolete APC-Cdc20 complex)) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0090544](http://purl.obolibrary.org/obo/GO_0090544) (null)) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0090530](http://purl.obolibrary.org/obo/GO_0090530) (null)) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0090509](http://purl.obolibrary.org/obo/GO_0090509) (null)) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0090484](http://purl.obolibrary.org/obo/GO_0090484) (null)) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0090450](http://purl.obolibrary.org/obo/GO_0090450) (null)) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0090418](http://purl.obolibrary.org/obo/GO_0090418) (obsolete positive regulation of transcription involved in S-phase of mitotic cell cycle)) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0090413](http://purl.obolibrary.org/obo/GO_0090413) (obsolete negative regulation of transcription from RNA polymerase II promoter involved in fatty acid biosynthetic process)) 39.52%


